| Dr Andrew Zorbis, MD | |
|
502 E New Haven Ave, Melbourne, FL 32901-5427 | |
| (321) 727-2020 | |
| (321) 984-9547 |
| Full Name | Dr Andrew Zorbis |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Location | 502 E New Haven Ave, Melbourne, Florida |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194775387 | NPI | - | NPPES |
| 180032667 | Other | FL | RAILROAD MEDICARE |
| 078217300 | Medicaid | FL | |
| 6448037002 | Other | FL | CIGNA |
| 48530 | Other | FL | BLUE CROSS / BLUE SHIELD |
| 2000384 | Other | FL | AETNA HMO |
| 4038897 | Other | FL | AETNA PPO |
| 154223 | Other | FL | CCN |
| 706303 | Other | FL | FIRST HEALTH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | ME35703 (Florida) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Andrew Zorbis, MD 502 E New Haven Ave, Melbourne, FL 32901-5427 Ph: (321) 727-2020 | Dr Andrew Zorbis, MD 502 E New Haven Ave, Melbourne, FL 32901-5427 Ph: (321) 727-2020 |
News Archive
Biomedical engineers at Duke University are adapting a rapid testing platform originally designed to detect Ebola to see whether it could be of use in detecting antigens to SARS-Cov-2, the virus that causes COVID-19.
A new drug has been approved to help sufferers of Crohn's disease, the U.S. Food and Drug Administration announced today. Cimzia (certolizumab pegol) received approval for adults with moderate to severe Crohn's disease who have not responded to conventional therapies. This product was approved with a Medication Guide.
While end-of-life care issues have come front and center in the current health care reform debate, physicians in the Pacific Northwest can now get more intensive training and new board certification in palliative medicine and hospice care.
Patients with advanced Parkinson disease (PD) who received deep brain stimulation treatment had more improvement in movement skills and quality of life after six months than patients who received other medical therapy, but also had a higher risk of a serious adverse events, according to a study in the January 7 issue of JAMA.
› Verified 9 days ago
Paul L Winslow Iii, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1649 W Eau Gallie Blvd, Suite 201, Melbourne, FL 32935 Phone: 321-622-5650 Fax: 321-622-5645 | |
Dr. Christopher S Shumake, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1995 W Nasa Blvd, Suite 200, Melbourne, FL 32904 Phone: 321-722-4443 Fax: 321-722-3657 | |
Dr. Daniel Mark Stingl, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1304 Oak St, Melbourne, FL 32901 Phone: 321-345-4002 Fax: 888-725-0512 | |
Dr. L Neal Freeman, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 502 E. New Haven Ave., Melbourne, FL 32901 Phone: 321-727-2020 Fax: 321-984-9547 | |
Dr. James N Mcmanus, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1995 W Nasa Blvd, Suite 200, Melbourne, FL 32904 Phone: 321-722-4443 Fax: 321-722-2334 | |
Regine M Pappas, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1649 W Eau Gallie Blvd, Ste 100, Melbourne, FL 32935 Phone: 321-255-4949 Fax: 321-255-0887 |